Filing Flows › Cardlytics (CDLX) › Q1 2026
Cardlytics (CDLX) Q1 2026 earnings results (first quarter 2026)
10-Q filed May 7, 2026
Cardlytics (CDLX) reported revenue of $34.3M for the first quarter 2026 (Q1 2026), -39% from a year earlier and -39% from the quarter before. Operating margin was -24.1%, net loss $4.5M (13.1% of revenue).
Cardlytics, Q1 2026: revenue $34.3M (-39% year over year), operating margin -24.1%, net loss $4.5M, operating cash flow −$5.6M. The chart follows the revenue to costs, profit and cash.
| Q1 2026 | Amount | Q/Q | Y/Y |
|---|---|---|---|
| Revenue | $34.3M | -39% | -39% |
| Operating profit | −$8.3M | — | — |
| Net earnings | −$4.5M | — | — |
| Operating cash flow | −$5.6M | -143% | — |
What changed
Revenue was $34.3M in Q1 2026, down 39% year over year and down 39% from the previous quarter. Engagement based pricing was the largest line at 67% of revenue. Served based pricing lost $14.8M year over year (down 60%), 67% of the total change.
Operating costs exceeded revenue by $8.3M, an operating margin of -24.1%. Total costs fell 37% while revenue fell 39%. The quarter ended with a net loss of $4.5M, narrower than the previous quarter's $8.2M loss. Non-operating items added $3.8M, -85% of pre-tax earnings, so the bottom line overstates operating performance.
Operating cash flow was −$5.6M. Non-cash charges added back $4.4M of depreciation and amortization and $4.8M of share-based compensation. Working capital and other items used $10.4M. Capital expenditures of $28K exceeded it, leaving free cash flow of −$5.7M.
Questions
What was Cardlytics' revenue in the first quarter 2026?
Cardlytics (CDLX) reported revenue of $34.3M for the first quarter 2026 (Q1 2026), -39% from a year earlier and -39% from the quarter before.
Was Cardlytics profitable in the first quarter 2026?
Operating loss was $8.3M (-24.1% of revenue) and net loss $4.5M.
Source: Cardlytics 10-Q on SEC EDGAR.